High Court Again Asked To Mull Patent Evidence Limits

Law360, New York (April 11, 2012, 5:41 PM EDT) -- A blood test manufacturer urged the U.S. Supreme Court on Monday to consider evidence limits in patent infringement disputes, four months after the court heard a case challenging applicants' ability to present new evidence to federal district courts if the patent office rejects their applications.

In a petition for writ of certiorari, blood test technology company Research & Diagnostics Systems Inc. asked the high court to review the amount of deference that should be given to U.S. Patent and Trademark Office administrative decisions after they are...
To view the full article, register now.